{"paper_id":"fd45fedf-a520-4fa9-8c73-a63babd16b63","body_text":"Zusammenfassung\nPatientinnen mit Endometriose präsentieren sich in der täglichen Praxis mit vielfältigen Symptomen. Die Erkrankung kann asymptomatisch bestehen oder mit starken Beschwerden assoziiert sein, oft stehen die Dysmenorrhö und der chronischer Unterbauchschmerz im Vordergrund. Die genaue Prävalenz ist unbekannt, dürfte aber bis zu 30 % betragen. Leider wird die Erkrankung trotz starker Beschwerden von nicht oder spät erkannt. Dabei wäre häufig ein „Drandenken“ ausreichend, um der Diagnose näher zu kommen. Die Definition von Risikofaktoren ist schwierig, einige scheinen aber zu bestehen und werden genannt. Auch die Entstehung von Endometriose ist nicht eindeutig geklärt, verschiedene Theorien existieren, werden weiterentwickelt und ergänzen sich gegenseitig. Die Diagnostik liegt mit einfachen Mitteln und Möglichkeiten eindeutig in den Händen der Gynäkologen, hierzu sind unsere Standarduntersuchungsverfahren meist ausreichend. Im Vordergrund stehen Anamnese, klinische Untersuchung mittels Spekulum, rektovaginale Untersuchung und die Sonografie. Selten werden Zusatzuntersuchungsverfahren nötig sein, sollten aber nicht ganz aus dem diagnostischen Repertoire verbannt werden. Insbesondere die Therapie ist von der Lebenssituation der Patientin abhängig und erfordert speziell bei Kinderwunschpatientinnen die Ausarbeitung eines Gesamtkonzepts unter Berücksichtigung aller Parameter.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nLiteratur\nAdamson GD, Pasta DJ (2010) Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril 94:1609–1615\nAghaey Meibody F et al (2011) Diagnosis of endometrial nerve fibers in women with endometriosis. Arch Gynecol Obstet 284:1157–1162\nAlhamdan D et al (2010) Mirena intra-uterine system: does it improve long term symptoms in women with chronic pelvic pain and/or endometriosis after laparoscopy? A multicentre randomized controlled trial. Rev Recent Clin Trials 5:143–146\nAl-Jefout M et al (2009) Diagnosis of endometriosis by detection of nerve fibres in an endometrial biopsy: a double-blind study. Hum Reprod 24:3019–3024\nBarcena de Arellano ML et al (2011) Influence of nerve growth factor in endometriosis-associated symptoms. Reprod Sci 18:1202–1210\nBrosens I, Brosens JJ, Benagiano G (2012) The eutopic endometrium in endometriosis: are the changes of clinical significance? Reprod Biomed Online 24:496–502\nBurghaus SKP, Fasching PA, Engel A et al (2012) Risk factors for endometriosis in a German Case-Control Study. Geburtsh Frauenheilkd 71:1073–1079\nCahill DJ (2002) What is the optimal medical management of infertility and minor endometriosis? Analysis and future prospects. Hum Reprod 17:1135–1140\nCahill DJ et al (1997) Ovarian dysfunction in endometriosis-associated and unexplained infertility. J Assist Reprod Genet 14:554–557\nCandiani GB et al (1991) Reproductive and menstrual factors and risk of peritoneal and ovarian endometriosis. Fertil Steril 56:230–234\nChapron C et al (2011) Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 26:2028–2035\nD’Hooghe TM, Xiao L, Hill JA (2001) Cytokine profiles in autologous peritoneal fluid and peripheral blood of women with deep and superficial endometriosis. Arch Gynecol Obstet 265:40–44\nDiagnosis and therapy of endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k-Level, AWMF Registry No. 045/015, August 2020). http://www.awmf.org/leitlinien/detail/ll/015-045.html\nDonnez J, Taylor HS, Stewart EA, Bradley L, Marsh E, Archer D, Al-Hendy A, Petraglia F, Watts N, Gotteland JP, Bestel E, Terrill P, Loumaye E, Humberstone A, Garner E (2022) Lancet 17;400(10356):896–907\nDoody MC, Gibbons WE, Buttram VC Jr (1988) Linear regression analysis of ultrasound follicular growth series: evidence for an abnormality of follicular growth in endometriosis patients. Fertil Steril 49:47–51\nGiudice LC et al (2022) Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet 399(10343):2267–2279 and Supplementary Appendix\nHassa H et al (2009) Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis. Arch Gynecol Obstet 279:891–895\nHudelist G, Fritzer N, Thomas A et al (2012) Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod 27:3412–3416\nKeckstein J et al (2021) The #Enzian classification: a comprehensive non-invasive and surgical description system for endometriosis. Acta Obstet Gynecol Scand 100(7):1165–1175\nKennedy S et al (2005) ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 20:2698–2704\nKhorram O et al (1993) Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol 169:1545–1549\nKnapp VJ (1999) How old is endometriosis? Late 17th- and 18th-century European descriptions of the disease. Fertil Steril 72:10–14\nKohler G et al (2010) A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis. Int J Gynaecol Obstet 108:21–25\nKunz G et al (2000) Structural abnormalities of the uterine wall in women with endometriosis and infertility visualized by vaginal sonography and magnetic resonance imaging. Hum Reprod 15:76–82\nLeslie C, Ma T, McElhinney B et al (2013) Is the detection of endometrial nerve fibers useful in the diagnosis of endometriosis? Int J Gynecol Pathol 32:149–155\nLeyendecker G et al (1996) Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum Reprod 11:1542–1551\nLeyendecker G et al (1998) Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update 4:752–762\nLeyendecker G et al (2002) Endometriosis results from the dislocation of basal endometrium. Hum Reprod 17:2725–2736\nLeyendecker G et al (2004) Uterine peristaltic activity and the development of endometriosis. Ann N Y Acad Sci 1034:338–355\nMahmood TA, Templeton A (1991) Prevalence and genesis of endometriosis. Hum Reprod 6:544–549\nMathur S, Garza DE, Smith LF (1990) Endometrial autoantigens eliciting immunoglobulin (Ig)G, IgA, and IgM responses in endometriosis. Fertil Steril 54:56–63\nMcLeod BS, Retzloff MG (2010) Epidemiology of endometriosis: an assessment of risk factors. Clin Obstet Gynecol 53:389–396\nMeyer R (1919) Über den Stand der Frage der Adenomyositis, Adenomyome im Allgemeinen und insbesondere über Adenomyositis seroepithelialis und Adenomyometritis sarcomatosa. Zentralbl Gynäkol 36:745–750\nMoen MH, Schei B (1997) Epidemiology of endometriosis in a Norwegian county. Acta Obstet Gynecol Scand 76:559–562\nNyholt DR et al (2012) Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet 44:1355–1359\nPainter JN et al (2011) Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet 43:51–54\nPetta CA, Ferriani RA, Abrao MS, Hassan D, Rosa E, Silva JC, Podgaec S, Bahamondes L (2005) Hum Reprod 20(7):1993–1998\nRousset-Jablonski C et al (2011) Catamenial pneumothorax and endometriosis-related pneumothorax: clinical features and risk factors. Hum Reprod 26:2322–2329\nSampson JA (1927) Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 3:93–110\nSchweppe KW (2003) Endometriose – Eine Erkrankung ohne Lobby. Zentralbl Gynäkol 125:233\nSimon C et al (1994) Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod 9:725–729\nSokolov DI et al (2005) Study of cytokine profile and angiogenic potential of peritoneal fluid in patients with external genital endometriosis. Bull Exp Biol Med 140:541–544\nStrowitzki T et al (2010a) Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 151:193–198\nStrowitzki T et al (2010b) Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 25:633–641\nStrowitzki T et al (2012) Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis. Int J Gynaecol Obstet 117:228–233\nSukhikh GT et al (2004) Cytokine production by immunocompetent cells of peritoneal fluid in women with external genital endometriosis. Bull Exp Biol Med 137:568–571\nSundqvist J et al (2013) Replication of endometriosis-associated single-nucleotide polymorphisms from genome-wide association studies in a Caucasian population. Hum Reprod 28:835–839\nTreloar SA et al (2005) Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet 77:365–376\nTummon IS et al (1988) Occult ovulatory dysfunction in women with minimal endometriosis or unexplained infertility. Fertil Steril 50:716–720\nUno S et al (2010) A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet 42:707–710\nVigano P et al (2004) Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 18:177–200\nWei DM et al (2011) [Relationship between endometriosis fertility index and pregnancies after laparoscopic surgery in endometriosis-associated infertility]. Zhonghua Fu Chan Ke Za Zhi 46:806–808\nXin L et al (2023) Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis. Arch Gynecol Obstet 2023 Jan 19\nXu H, Zhang MGC et al (2013) Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis. Angiogenesis 16:541–551\nYin X et al (2012) Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis. J Clin Endocrinol Metab 97:E35–E43\nZafrakas M et al (2008) Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differenziation rather than malignant potential. Int J Mol Med 21:335–344\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2024 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature\nAbout this chapter\nCite this chapter\nRenner, S.P., Müller, A. (2024). Endometriose. In: Strowitzki, T., Ortmann, O. (eds) Klinische Endokrinologie für Frauenärzte. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-65517-7_12\nDownload citation\nDOI: https://doi.org/10.1007/978-3-662-65517-7_12\nPublished:\nPublisher Name: Springer, Berlin, Heidelberg\nPrint ISBN: 978-3-662-65516-0\nOnline ISBN: 978-3-662-65517-7\neBook Packages: Medicine (German Language)","source_license":"CC0","license_restricted":false}